The Latest in Amyloidosis Care and Research with Morie Gertz, MD, Mayo Clinic image

The Latest in Amyloidosis Care and Research with Morie Gertz, MD, Mayo Clinic

Jul 25, 2024
11:00AM MDT
Online Event
Overview

This show will not be live streamed. You can submit your questions in advance by clicking the button "Notify when available." 

Learn about the latest in amyloidosis care and clinical research with a review of up-to-date care and open clinical trials from amyloidosis expert Morie Gertz, MD. Learn about how HealthTree's research work is advancing Dr. Gertz's work to better understand why amyloidosis patients are obtaining a delayed diagnosis and why that matters to patient outcomes.

 

Agenda
11:00 AM
Welcome
Jennifer Ahlstrom

Welcome, Announcements & Introduction

11:05 AM
Discussion with Dr. Morie Gertz,
Morie Gertz, MD, MACP

 

 

11:50 AM
Q&A
Audience

Audience is able to submit their questions in advance so Dr. Morie Gertz, can answer during the discussion.

Speakers & Moderators
Healthtree contact Jennifer Ahlstrom

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Healthtree contact Morie Gertz, MD, MACP

Morie Gertz, MD, MACP

Morie Gertz, MD, MACP, is the Roland Seidler, Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, MN. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Gertz has also served as Treasurer of the International Myeloma Society and President of Mayo Staff Officers and Councilors. He was the Chair of the Mayo Personnel Committee. Currently he serves on the American Society of Hematology Training Program Committee and the American Board of Internal Medicine Hematology Board Exam Committee. Dr. Gertz has been recognized with the 2014 Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström Macroglobulinemia and is a Mayo Distinguished Clinician. He has been recognized for his contributions in amyloidosis and Waldenström macroglobulinemia, has authored more than five hundred peer-reviewed publications, and is a master of the America College of Physicians. He graduated from Northwestern University with highest distinction as a Phi Beta Kappa and received his medical degree cum laude from Loyola Medical School and was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush Presbyterian St. Luke’s Hospital in Chicago and was twice voted Resident of the Year.